OTCMKTS:EQUR E-Qure (EQUR) Stock Price, News & Analysis → The #1 Opportunity of the decade? (From Behind the Markets) (Ad) Free EQUR Stock Alerts $0.0002 0.00 (0.00%) (As of 10/5/2023) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.00▼$0.05VolumeN/AAverage VolumeN/AMarket Capitalization$9,358.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get E-Qure alerts: Email Address Ad Behind the MarketsThe #1 Opportunity of the decade?It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.Click here to learn more >>> About E-Qure Stock (OTCMKTS:EQUR)E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.Read More EQUR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EQUR Stock News HeadlinesFebruary 9, 2024 | ft.comLabour’s equal pay plan for ethnic minorities is all stakeholder, and no substanceDecember 8, 2023 | bbc.comIs equal pay actually possible?April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.December 5, 2023 | nasdaq.comEqual Is Not FairSeptember 29, 2023 | bbc.co.ukStrikes: Health workers call for equal treatment over paySeptember 27, 2023 | bbc.comLaw would give island's same-sex parents equal rightsSeptember 23, 2023 | bbc.comBrexit: EU-derived equal pay protections to be retainedSeptember 12, 2023 | nypost.comTotal number of FDNY members who’ve died from a 9/11-related illness nearly equals how many died at Ground Zero: officialsApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.June 24, 2023 | forbes.comHere Are 3 Things Every Woman Needs To Know About Equal Pay DayJune 1, 2023 | nasdaq.comMarketSite at Times SquareMay 10, 2023 | travel.usnews.comTimes SquareMay 10, 2023 | bbc.co.ukSquare and square rootApril 21, 2023 | marketwatch.comHomeschooling Market Size, Business Segments, Innovative Strategies And Outlook by 2030| Foxford, K12 Inc, Time4LearningApril 10, 2023 | cbsnews.comStarlite Deli closing Times Square location at end of AprilMarch 28, 2023 | forbes.comClover vs Square POS (2023 Comparison)March 18, 2023 | nytimes.comThe Best Combination SquareMarch 15, 2023 | marketwatch.comLockout And Tagout Market (Size and Share) 2023-2029 with Key Players Analysis | Survey by Absolute ReportsMarch 2, 2023 | forbes.comSquare Invoices Review 2023: Features, Pricing & MoreFebruary 15, 2023 | msn.comTraffic police request SPPU students to use alternative entranceFebruary 8, 2023 | finance.yahoo.comAnnual Square Report Reveals Canadian Businesses All-In on Automation and Tech Innovation in 2023November 3, 2022 | msn.comuniQure: Q3 Earnings InsightsSeptember 18, 2022 | finance.yahoo.comE-Qure Corp. (EQUR)September 10, 2022 | reuters.comQURE.O - Uniqure NV | Stock Price & Latest News | ReutersAugust 2, 2022 | finance.yahoo.comuniQure N.V.'s (NASDAQ:QURE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?January 7, 2022 | nasdaq.comEQUR Real-Time QuotesSee More Headlines Receive EQUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for E-Qure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/17/2020Today4/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous durable goods Sub-IndustryN/A Current SymbolOTCMKTS:EQUR CUSIPN/A CIK1563536 Webwww.e-qure.com Phone(972) 916-7333Fax972-8916-7331Employees1Year Founded2014Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares46,790,000Free Float9,530,000Market Cap$9,358.00 OptionableNot Optionable Beta0.93 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Ohad Goren (Age 52)CEO & Director Comp: $144kMr. Gal Peleg (Age 45)Chief Financial Officer Comp: $18kMr. Itsik Ben Yesha (Age 70)CTO & Director Comp: $168.59kKey CompetitorsRenovaCareOTCMKTS:RCARGlobal WholeHealth PartnersOTCMKTS:GWHPiNeedMDOTCMKTS:NEMDGenocea BiosciencesNASDAQ:GNCAHTG Molecular DiagnosticsNASDAQ:HTGMQView All Competitors EQUR Stock Analysis - Frequently Asked Questions How have EQUR shares performed in 2024? E-Qure's stock was trading at $0.0002 at the beginning of the year. Since then, EQUR stock has increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. How were E-Qure's earnings last quarter? E-Qure Corp. (OTCMKTS:EQUR) issued its earnings results on Thursday, September, 17th. The company reported ($0.01) EPS for the quarter. What other stocks do shareholders of E-Qure own? Based on aggregate information from My MarketBeat watchlists, some companies that other E-Qure investors own include HEXO (HEXO), Bertrandt Aktiengesellschaft (BDT), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY), Aeolus Pharmaceuticals (AOLS), Advanced Micro Devices (AMD), Akari Therapeutics (AKTX), Adicet Bio (ACET) and Aurora Cannabis (ACB). How do I buy shares of E-Qure? Shares of EQUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EQUR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding E-Qure Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.